Eversept Partners’s IVERIC bio ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-350,747
Closed -$7.51M – 82
2022
Q4
$7.51M Buy
+350,747
New +$7.49M 0.66% 34
2018
Q4
– Sell
-149,100
Closed -$352K – 70
2018
Q3
$352K Hold
149,100
– – 0.15% 57
2018
Q2
$407K Hold
149,100
– – 0.19% 62
2018
Q1
$409K Hold
149,100
– – 0.19% 52
2017
Q4
$465K Buy
+149,100
New +$419K 0.27% 38

Other funds holding ISEE

Eversept Partners's ISEE Position: Q1 2023 in Review

Eversept Partners sold out of IVERIC bio (ISEE) in Q1 2023, closing a stake of 350,747 shares — an estimated $7.51M sold.

Eversept Partners first reported a position in ISEE in Q4 2017 and held it in 5 quarters. The position peaked at $7.51M in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

  • Eversept Partners reported no remaining IVERIC bio position as of Q1 2023 after selling out during the quarter.
  • Eversept Partners sold 350,747 IVERIC bio shares in Q1 2023, an estimated $7.51M.
  • Eversept Partners first reported a position in IVERIC bio in Q4 2017 and held it in 5 quarters.
  • Eversept Partners's IVERIC bio position peaked at $7.51M in Q4 2022.
  • 223 funds tracked by Wall St. Rank held IVERIC bio as of Q1 2023.

Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.